Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoWed 23 Jan 13 | 06:43 AM ET Marc Beer, Aegerion Pharmaceuticals CEO, discusses a drug in the company's pipeline that treats patients with severe cholesterol disorder.Saturday, February 16, 2013
Aegerion CEO on Promise of Biopharma
Highlight transcript below to create clipTranscript: Print | Email Go Click text to jump within videoWed 23 Jan 13 | 06:43 AM ET Marc Beer, Aegerion Pharmaceuticals CEO, discusses a drug in the company's pipeline that treats patients with severe cholesterol disorder.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment